Project Inform
Information, inspiration and advocacy for people with HIV/AIDS and hepatitis C
Skip to content
  • Home|
  • About Us|
    • What we do|
    • Our mission|
    • Testimonials|
    • Staff and Board|
    • Volunteers, employment|
    • Media|
    • Staff pets|
    • Financial statements|
    • Martin Delaney|
    • Contact|
  • AIDS Walk|
  • Information|
    • HIV Health & Wellness|
    • HCV / HIV Coinfection|
    • PrEP|
    • Other publications|
    • Research in HIV|
    • Research in hepatitis C|
    • Other research areas|
    • Sign up for PIP eNews|
  • Help lines|
    • HELP-4-HEP (hep C)|
    • HIV Health InfoLine|
  • Support us|
    • Donate Now|
    • Other ways to give|
    • Events|
    • Agency newsletter|
  • Facebook
  • Twitter
  • RSS Feed
  • Donate Now

Sign up for our e-newsletter

* = required field
Please leave this field empty
  • HIV cure advocacy
  • HIV care & treatment
  • HIV prevention
  • HIV policy
  • Hepatitis C care & treatment
  • Hepatitis C policy
  • Health care reform
  • CONTRIBUTORS

Twitter Feed

Project Inform

ProjectInform

  • ProjectInform RT @aidswalksf : Next year, the AIDS Walk will benefit @ProjectInform ! Learn more about the organization here: http://t.co/wdfyVRfuwa

    17 hours . reply . retweet . favorite

  • ProjectInform PrEPnews: Don't miss! Excellent webinar, women & PrEP, hosted by @HIVpxresearch . Mon, Sept 16, 1-2:30p EST. Register: http://t.co/CiVRqcL6db

    22 hours . reply . retweet . favorite

  • ProjectInform PrEPnews: Towelroad picks up http://t.co/2DSLr5GWU8 article ... "The silence of gay men on Truvada". http://t.co/2DSLr5GWU8

    22 hours . reply . retweet . favorite

  • ProjectInform HIVnews: Great to meet and talk to all of you at USCA this year! @pozmagazine @HIVpxresearch @HIVInSite

    22 hours . reply . retweet . favorite

  • ProjectInform HIVnews: Great to meet and talk to all of you at USCA this year! @CHPIRduke @STLEFA @UntilOrg @VOAGBR @BridgeHIV @PosAware

    22 hours . reply . retweet . favorite

  • ProjectInform HIVnews: Great to meet and talk to all of you at USCA this year! @GCAPNOW @UTSWNews @LASchs @TheBodyDotCom @AIDSHelpHouston @HealthHIV

    23 hours . reply . retweet . favorite

  • ProjectInform Congratulations @emilymckoy27 ! You're our 2000th follower. Thanks for getting us there!

    1 day . reply . retweet . favorite

  • ProjectInform @nazeer_kokoshe Thank you for following!

    2 days . reply . retweet . favorite

  • ProjectInform @ReignGwapito Thank you for following!

    2 days . reply . retweet . favorite

  • ProjectInform @ACTGNetwork Thank you for following!

    2 days . reply . retweet . favorite

join the conversation
By: Web Design Company

Coverage from 2013 International AIDS Society Conference, Kuala Lumpur

slide_ias2013

Potential HIV remission in two transplant recipients

American HIV treatment Guidelines get it right

Study offers more details on people who control HIV after stopping ARVs

Study shows starting treatment earlier reduces HIV reservoir, improves health over time

BIT225 reduces HIV reservoirs

Very long acting treatment (1 dose per month) is moderately well tolerated

Switching to etravirine (Intelence) improves levels of blood fats

New integrase inhibitor dolutegravir shows potent suppression with few side effects

High rate of re-infection with hepatitis C seen in HIV-positive gay men

FibroScan can predict risk of liver damage among people with HIV and hepatitis C

Novel scoring system in early infection may help predict who should start treatment sooner

Life expectancy for people with HIV jumps 15 years, but not equally for everyone

Study shows low but detectable HIV levels in semen of some men despite being “undetectable” in blood

Intimate partner violence changes how men who have sex with men use condoms

Providers who intitiate HIV testing uncover more acute infection in MSM

© 2013 PROJECT INFORM  273 Ninth Street  San Francisco, CA 94103  415-558-8669
HELP-4-HEP (Hepatitis C Helpline)  1-877-435-7443  9am-7pm EST Mon-Fri HIV Health InfoLine  1-800-822-7422  10a-4p Mon-Fri PST
  • Facebook
  • Twitter
  • RSS Feed
  • Home|
  • About us|
  • Publications|
  • Help lines|
  • Support us|
  • E-newsletter|
  • Disclaimer|
  • Contact|
  • Privacy|
  • Feedback|
  • DONATE NOW|
  • Somethumb|
RSS